Generative AI Plan for Care Lab Study
Generative AI Pre-visit Lab Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Bhavna Daryani, BDS
- Phone Number: 2018859852
- Email: bhavnad@google.com
Study Locations
-
-
California
-
Mountain View, California, United States, 94043
- Recruiting
- Google LLC
-
Contact:
- Matthew Thompson, MD
- Phone Number: 6506090742
- Email: mthomp@google.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age of majority: are of legal adult age (18 or older in most US states; 19 or older in Nebraska & Alabama, or 21 or older in Mississippi)
- Resides in the United States
- Fitbit mobile user using their Google accounts on an Android smartphone
- Able to read, write and willing to consent in English
Exclusion Criteria:
- Enrollment using a corporate google.com account
- Have a condition or circumstance that the investigator determines as inappropriate for participation.
- Have a chief complaint or symptoms that are potentially related to mental health disorders, sexually transmitted diseases or infections, or pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Arm A - Baseline
Baseline Urgency and Baseline Pre-visit Model
|
Plan for Care baseline model
|
|
Experimental: Arm B - Urgency and Pre-visit Model 1
Urgency and Pre-visit Model 1
|
A user informational tool using generative AI models
|
|
Experimental: Arm C - Urgency and Pre-visit Model 2
Urgency and Pre-visit Model 2
|
A user informational tool using generative AI models
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Self-Reported assessment
Time Frame: Day 1
|
Determine participants' self-reported assessment of the pre-visit experience, such as satisfaction on a likert scale
|
Day 1
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- GH-BMX-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.